NCT02276196View on ClinicalTrials.gov

Effect of LIXIsenatide on the Renal System

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Diabetic Kidney DiseaseDiabetic NephropathyDiabetes MellitusGlucagon-Like Peptide 1
Interventions
DRUG

Lixisenatide

GLP-1 receptor agonist

DRUG

Insulin glulisine

Insulin analogue

Trial Locations (1)

1081 HV

VU Universtiy Medical Center, Amsterdam

All Listed Sponsors
lead

Amsterdam UMC, location VUmc

OTHER

NCT02276196 - Effect of LIXIsenatide on the Renal System | Biotech Hunter | Biotech Hunter